Regulated expression of the α isoform of the human thromboxane A2 receptor during megakaryocyte differentiation : a coordinated role for WT1, Egr1 & Sp1
Files in This Item:
|Gannon et al,SP1,EgR1 & WT1 Reg of TP Prm1 by PMA inc Supp JMB 2009.pdf||1.46 MB||Adobe PDF||Download|
|Title:||Regulated expression of the α isoform of the human thromboxane A2 receptor during megakaryocyte differentiation : a coordinated role for WT1, Egr1 & Sp1||Authors:||Gannon, AnneMarie
Turner, Elizebeth C.
Reid, Helen M.
Kinsella, B. Therese
|Permanent link:||http://hdl.handle.net/10197/3166||Date:||20-Nov-2009||Online since:||2011-09-22T15:15:25Z||Abstract:||Thromboxane plays an essential role in haemostasis, regulating platelet aggregation and vessel tone. In humans, it signals through the TPalpha and TPbeta isoforms that are transcriptionally regulated by distinct promoters, Prm1 and Prm3, respectively. Herein, the consequence of megakaryocytic differentiation on Prm1-directed TPα expression was investigated. Phorbol ester (PMA) treatment substantially increased TPα mRNA and Prm1-directed gene expression in human erythroleukemia (HEL) and K562 cells. Deletional analyses localized the major responsive element(s) to the upstream -8500 and -7504 region while mutation of four WT1/Egr1/Sp1 cis-elements therein established that each contribute to the induction. Moreover, PMA increased Egr1, but not WT1 or Sp1, expression while the NAB1 co-repressor impaired PMA-induction of Egr1 and Prm1-directed gene expression. Chromatin immunoprecipitations established that WT1 is predominantly bound in vivo to the 5’ Prm1 region in non-differentiated HEL cells. In response to PMA, there was initial induction in Egr1 and associated reduction in WT1 binding to Prm1 in vivo which was displaced by Sp1 following sustained treatment. Collectively, data establish that regulated WT1 followed by sequential Egr1 and Sp1 binding to elements within Prm1 mediate repression and subsequent induction of TPα during differentiation into the megakaryocytic phenotype, shedding significant insights into factors regulating TPa expression therein.||Funding Details:||Science Foundation Ireland
Health Research Board
|Type of material:||Journal Article||Publisher:||Elsevier||Journal:||Journal of Molecular Biology||Volume:||394||Issue:||1||Start page:||29||End page:||45||Copyright (published version):||2009 Elsevier Ltd.||Keywords:||Thromboxane receptor; Megakaryocytic differentiation; WT1; Egr1; Sp1; Transcription; Gene||Subject LCSH:||Thromboxanes
|DOI:||10.1016/j.jmb.2009.09.007||Other versions:||http://dx.doi.org/10.1016/j.jmb.2009.09.007||Language:||en||Status of Item:||Peer reviewed|
|Appears in Collections:||Conway Institute Research Collection|
Biomolecular and Biomedical Science Research Collection
Show full item record
This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.